Published in Antimicrob Agents Chemother on May 01, 1986
Primary structure of an aminoglycoside 6'-N-acetyltransferase AAC(6')-4, fused in vivo with the signal peptide of the Tn3-encoded beta-lactamase. J Bacteriol (1987) 3.05
Use of plasmid profiles in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance. Clin Microbiol Rev (1988) 2.35
Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase. Antimicrob Agents Chemother (1990) 1.73
Tn1331, a novel multiresistance transposon encoding resistance to amikacin and ampicillin in Klebsiella pneumoniae. Antimicrob Agents Chemother (1987) 1.36
Transposon-mediated amikacin resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother (1988) 1.03
Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid. Antimicrob Agents Chemother (1991) 0.90
Heterogeneity of 6'-N-acetyltransferases of type 4 conferring resistance to amikacin and related aminoglycosides in members of the family Enterobacteriaceae. Antimicrob Agents Chemother (1988) 0.79
Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun (1981) 13.80
Aminoglycoside-modifying enzymes. Methods Enzymol (1975) 8.38
Plasmid-determined resistance to antimicrobial agents. Annu Rev Microbiol (1978) 8.35
Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev (1983) 5.45
Incompatibility groups and the classification of fi - resistance factors. J Bacteriol (1972) 4.91
Compatibility groups among fi - R factors. Nature (1971) 4.43
BB-K 8, a new semisynthetic aminoglycoside antibiotic. J Antibiot (Tokyo) (1972) 3.02
Translocation of sequences encoding antibiotic resistance from the chromosome to a receptor plasmid in Salmonella ordonez. Mol Gen Genet (1981) 2.22
Amikacin resistance mediated by multiresistance transposon Tn2424. J Bacteriol (1983) 2.15
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. J Infect Dis (1985) 1.92
Epidemiological studies of aminoglycoside resistance in the U.S.A. J Antimicrob Chemother (1981) 1.75
Acetylation of amikacin, a new semisynthetic antibiotic, by Pseudomonas aeruginosa carrying an R factor. Antimicrob Agents Chemother (1975) 1.52
Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med (1984) 1.50
Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli. JAMA (1982) 1.31
Characterization of aminoglycoside 6'-N-acetyltransferases [AAC(6')] from gram-negative bacteria and Streptomyces kanamyceticus. J Antimicrob Chemother (1985) 1.14
Purification of two forms of kanamycin acetyltransferase from Escherichia coli. Arch Biochem Biophys (1984) 1.08
Plasmid-mediated aminoglycoside phosphotransferases in Haemophilus ducreyi. Antimicrob Agents Chemother (1985) 1.07
Epidemiological aspects of aminoglycoside resistance in France. J Antimicrob Chemother (1981) 0.98
Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns. J Infect Dis (1976) 0.93
[Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals]. Nouv Presse Med (1979) 0.84
Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis (1991) 4.82
Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis (1985) 4.52
Inducible resistance to vancomycin in Enterococcus faecium D366. J Infect Dis (1989) 4.34
Bacterial persistence in streptococcal endocarditis due to thiol-requiring mutants. J Infect Dis (1971) 4.06
Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors. Antimicrob Agents Chemother (1988) 3.57
Vancomycin-resistant streptococci or Leuconostoc sp. Antimicrob Agents Chemother (1985) 3.57
Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J Bacteriol (1980) 3.55
Mediastinitis due to multiple resistant Corynebacterium xerosis. Clin Infect Dis (1993) 3.14
Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev Infect Dis (1988) 3.12
Primary structure of an aminoglycoside 6'-N-acetyltransferase AAC(6')-4, fused in vivo with the signal peptide of the Tn3-encoded beta-lactamase. J Bacteriol (1987) 3.05
Use of penicillin-binding proteins for the identification of enterococci. J Gen Microbiol (1986) 2.87
Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256. Antimicrob Agents Chemother (1990) 2.70
Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob Agents Chemother (1991) 2.68
Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases. Antimicrob Agents Chemother (1986) 2.63
SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother (1989) 2.60
Technical advance: application of high-performance liquid chromatography with photodiode array detection to the metabolic profiling of plant isoprenoids. Plant J (2000) 2.31
Inducible carboxypeptidase activity in vancomycin-resistant enterococci. Antimicrob Agents Chemother (1992) 2.30
Chloramphenicol resistance in Streptococcus pneumoniae: enzymatic acetylation and possible plasmid linkage. Antimicrob Agents Chemother (1978) 2.27
The H-NS protein is involved in the biogenesis of flagella in Escherichia coli. J Bacteriol (1994) 2.24
Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. J Antimicrob Chemother (1996) 2.21
Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams. Antimicrob Agents Chemother (1983) 2.15
Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups. J Biol Chem (1977) 2.13
Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob Agents Chemother (1990) 2.08
Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest (1995) 2.04
Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis. Eur J Clin Microbiol (1982) 2.01
Comparison of vancomycin-inducible proteins from four strains of Enterococci. FEMS Microbiol Lett (1990) 2.01
Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother (1992) 1.96
Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis (1992) 1.93
A transferable kanamycin resistance plasmid isolated from Haemophilus influenzae. Ann Microbiol (Paris) (1975) 1.92
[The natural resistance of staphylococci to methicillin and oxacillin]. Rev Fr Etud Clin Biol (1965) 1.90
Multidrug-resistant human and animal Salmonella typhimurium isolates in France belong predominantly to a DT104 clone with the chromosome- and integron-encoded beta-lactamase PSE-1. J Infect Dis (1999) 1.83
A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1996) 1.77
Insertion of a novel DNA sequence, 1S1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol Microbiol (1994) 1.74
Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation. Clin Microbiol Infect (2002) 1.74
Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid. Antimicrob Agents Chemother (1993) 1.73
Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa. Microbiology (1998) 1.72
Broad-spectrum, transmissible beta-lactamases. N Engl J Med (1988) 1.70
Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis (1995) 1.68
Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis (1997) 1.63
Low-level resistance to fluoroquinolones among Salmonella and Shigella. Clin Microbiol Infect (2000) 1.63
Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother (1990) 1.58
Role of ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A beta-lactamase Sme-1. Biochim Biophys Acta (1999) 1.58
Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii. Antimicrob Agents Chemother (1998) 1.56
Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem. J Mol Biol (2001) 1.54
Transferable plasmid-mediated antibiotic resistance in Acinetobacter. Plasmid (1983) 1.52
Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid. Antimicrob Agents Chemother (1991) 1.52
Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis (1986) 1.50
Analysis of peptidoglycan precursors in vancomycin-resistant enterococci. Antimicrob Agents Chemother (1992) 1.50
Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance. J Infect Dis (1998) 1.48
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. J Antimicrob Chemother (1979) 1.47
In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content. J Antimicrob Chemother (1985) 1.46
The new quinolones and their combinations with other agents for therapy of severe infections. J Antimicrob Chemother (1986) 1.46
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect (2006) 1.45
Antagonism of the antibacterial action of some penicillins by other penicillins and cephalosporins. J Clin Invest (1975) 1.45
Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J Bacteriol (1995) 1.44
Useful oldies: oral antibiotics for the treatment of MRSA infections. J Hosp Infect (2004) 1.39
Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae. J Antimicrob Chemother (1985) 1.39
Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins. Antimicrob Agents Chemother (Bethesda) (1970) 1.38
In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. Ann Microbiol (Paris) (1983) 1.36
Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob Agents Chemother (1997) 1.34
International comparison of prevalence of resistance to antibiotics. JAMA (1978) 1.34
Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam). Antimicrob Agents Chemother (1986) 1.32
Serratia marcescens infections. Infect Control (1986) 1.30
Two mammalian cell internalization strategies used by pathogenic bacteria. Annu Rev Genet (1994) 1.29
The changing pattern of trimethoprim resistance in Paris, with a review of worldwide experience. Rev Infect Dis (1986) 1.29
Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro. Antimicrob Agents Chemother (1998) 1.28
Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J Antimicrob Chemother (1990) 1.26
N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci. Antimicrob Agents Chemother (1994) 1.25
New bacteriological aspects of infective endocarditis. Eur Heart J (1984) 1.22
Epidemiology of quinolone resistance: Europe and North and South America. Drugs (1995) 1.22
Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. J Antimicrob Chemother (2000) 1.20
Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J Clin Microbiol (1978) 1.19
Isolation of eukaryotic ribosomal proteins. Purification and characterization of the 60 S ribosomal subunit proteins La, Lb, Lf, P1, P2, L13', L14, L18', L20, and L38. J Biol Chem (1978) 1.19
A silent carbapenemase gene in strains of Bacteroides fragilis can be expressed after a one-step mutation. FEMS Microbiol Lett (1992) 1.18
Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: observations in vitro and in vivo. J Infect Dis (1973) 1.17
A recent fixation of cfiA genes in a monophyletic cluster of Bacteroides fragilis is correlated with the presence of multiple insertion elements. J Bacteriol (1996) 1.17
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria. J Antimicrob Chemother (1990) 1.14
The chromosomal 3',5"-aminoglycoside phosphotransferase in Streptococcus pneumoniae is closely related to its plasmid-coded homologs in Streptococcus faecalis and Staphylococcus aureus. J Bacteriol (1983) 1.13
Native valve endocarditis caused by Staphylococcus capitis. Eur J Clin Microbiol Infect Dis (1993) 1.13
Nutritionally deficient streptococci: electron microscopic study of 14 strains isolated in bacterial endocarditis. Ann Microbiol (Paris) (1981) 1.13
Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience. Rev Infect Dis (1985) 1.13
Diffusion of beta-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and -resistant strains of Enterobacter cloacae. J Gen Microbiol (1992) 1.12
Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers. J Antimicrob Chemother (1983) 1.12